Literature DB >> 16682479

Changes in activation states of murine polymorphonuclear leukocytes (PMN) during inflammation: a comparison of bone marrow and peritoneal exudate PMN.

Takuya Itou1, L Vincent Collins, Fredrik B Thorén, Claes Dahlgren, Anna Karlsson.   

Abstract

To study different activation states in polymorphonuclear leukocytes (PMN) in mice, we compared the function of murine PMN obtained from the bone marrow (BMPMN) with those of PMN obtained by intraperitoneal induction with thioglycolate (TGPMN) or uric acid (UAPMN). When stimulated with chemotactic peptides, e.g., formyl-methionyl-leucyl-phenylalanine (fMLF), WKYMVM, or WKYMVm, the TGPMN and UAPMN showed greatly enhanced generation of reactive oxygen species (ROS) compared with BMPMN, which suggests that exudation to the peritoneum per se induces a primed state in the cells. The WKYMVm peptide was the most potent stimulant of ROS generation, and it desensitized for subsequent stimulation with fMLF or WKYMVM. This desensitization was broken by the addition of cytochalasin B. The TGPMN and UAPMN appeared to be fully primed, since no increase in response was induced by pretreatment with tumor necrosis factor alpha (TNF-alpha). In contrast, the BMPMN response was increased 2.5- to 3-fold. The differences in oxidative responses were supported by degranulation studies. Preincubation with TNF-alpha promoted CR3 expression on BMPMN, and this level of expression was also enhanced by WKYMVm. In contrast, CR3 expression on untreated TGPMN and UAPMN was already similar to that on TNF-alpha-primed BMPMN and could be only slightly enhanced by TNF-alpha treatment. Taken together, these results indicate that BMPMN are in a resting state and have the capacity to become primed, while peritoneal exudate PMN are already fully primed upon isolation. These results have major implications for murine neutrophil research and show the importance of defining which PMN subsets to use when investigating murine models.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682479      PMCID: PMC1459655          DOI: 10.1128/CVI.13.5.575-583.2006

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  38 in total

1.  Flow cytometric identification of murine neutrophils and monocytes.

Authors:  E Lagasse; I L Weissman
Journal:  J Immunol Methods       Date:  1996-10-16       Impact factor: 2.303

2.  The N-formylpeptide receptor (FPR) and a second G(i)-coupled receptor mediate fMet-Leu-Phe-stimulated activation of NADPH oxidase in murine neutrophils.

Authors:  Mark C Lavigne; Philip M Murphy; Thomas L Leto; Ji-Liang Gao
Journal:  Cell Immunol       Date:  2002 Jul-Aug       Impact factor: 4.868

3.  Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites.

Authors:  M Hansson; A Asea; U Ersson; S Hermodsson; K Hellstrand
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

4.  Cellular response to various chemical stimulants in the peritoneal cavity of the mouse.

Authors:  J L Kaw; E G Beck
Journal:  Jpn J Exp Med       Date:  1982-10

5.  Molecular determinants of monosodium urate crystal-induced murine peritonitis: a role for endogenous mast cells and a distinct requirement for endothelial-derived selectins.

Authors:  S J Getting; R J Flower; L Parente; R de Medicis; A Lussier; B A Woliztky; M A Martins; M Perretti
Journal:  J Pharmacol Exp Ther       Date:  1997-10       Impact factor: 4.030

Review 6.  Neutrophil priming in host defense: role of oxidants as priming agents.

Authors:  Steve D Swain; Troy T Rohn; Mark T Quinn
Journal:  Antioxid Redox Signal       Date:  2002-02       Impact factor: 8.401

7.  Priming of human neutrophil functions by tumor necrosis factor: enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe.

Authors:  M S Bajaj; R R Kew; R O Webster; T M Hyers
Journal:  Inflammation       Date:  1992-06       Impact factor: 4.092

8.  Endogenous reactive oxygen intermediates activate tyrosine kinases in human neutrophils.

Authors:  J H Brumell; A L Burkhardt; J B Bolen; S Grinstein
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

9.  Deficiency of Src family kinases p59/61hck and p58c-fgr results in defective adhesion-dependent neutrophil functions.

Authors:  C A Lowell; L Fumagalli; G Berton
Journal:  J Cell Biol       Date:  1996-05       Impact factor: 10.539

10.  Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid.

Authors:  Z Liu; J M Shipley; T H Vu; X Zhou; L A Diaz; Z Werb; R M Senior
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

View more
  31 in total

1.  Local TNFR1 Signaling Licenses Murine Neutrophils for Increased TLR-Dependent Cytokine and Eicosanoid Production.

Authors:  Jacques Deguine; Jessica Wei; Roman Barbalat; Karsten Gronert; Gregory M Barton
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

2.  Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice.

Authors:  Omar M Khan; Mohamed X Ibrahim; Ing-Marie Jonsson; Christin Karlsson; Meng Liu; Anna-Karin M Sjogren; Frida J Olofsson; Mikael Brisslert; Sofia Andersson; Claes Ohlsson; Lillemor Mattsson Hultén; Maria Bokarewa; Martin O Bergo
Journal:  J Clin Invest       Date:  2011-01-25       Impact factor: 14.808

3.  Pro-oxidant versus anti-oxidant effects of seeds aglycone extracts of Lepidium sativum and Eruca vesicaria Linn., in vitro, and on neutrophil nitro-oxidative functions.

Authors:  Nabila Tounsi; Bahia Djerdjouri; Ouahiba Ait Yahia; Aicha Belkebir
Journal:  J Food Sci Technol       Date:  2019-08-14       Impact factor: 2.701

4.  Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.

Authors:  Max Eberle; Philipp Ebel; Christoph A Mayer; Julia Barthelmes; Nadja Tafferner; Nerea Ferreiros; Thomas Ulshöfer; Marina Henke; Christian Foerch; Anika Männer de Bazo; Sabine Grösch; Gerd Geisslinger; Klaus Willecke; Susanne Schiffmann
Journal:  Immunol Cell Biol       Date:  2015-04-02       Impact factor: 5.126

5.  ADAM17 activity and other mechanisms of soluble L-selectin production during death receptor-induced leukocyte apoptosis.

Authors:  Yue Wang; Adam C Zhang; Zhenya Ni; Amy Herrera; Bruce Walcheck
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

6.  An Anti-Inflammatory Role for NLRP10 in Murine Cutaneous Leishmaniasis.

Authors:  Gwendolyn M Clay; Diogo G Valadares; Joel W Graff; Tyler K Ulland; Richard E Davis; Breanna M Scorza; Bayan Sudan Zhanbolat; Yani Chen; Fayyaz S Sutterwala; Mary E Wilson
Journal:  J Immunol       Date:  2017-09-20       Impact factor: 5.422

7.  Do neutrophils play a role in establishing liver abscesses and distant metastases caused by Klebsiella pneumoniae?

Authors:  Jung-Chung Lin; Feng-Yee Chang; Chang-Phone Fung; Kuo-Ming Yeh; Chiung-Tong Chen; Yu-Kuo Tsai; L Kristopher Siu
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

8.  Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.

Authors:  Zvi G Fridlender; Jing Sun; Samuel Kim; Veena Kapoor; Guanjun Cheng; Leona Ling; G Scott Worthen; Steven M Albelda
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

9.  Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils.

Authors:  Heike L Rittner; Dagmar Hackel; Philipp Voigt; Shaaban Mousa; Andrea Stolz; Dominika Labuz; Michael Schäfer; Michael Schaefer; Christoph Stein; Alexander Brack
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

10.  Mice chronically fed high-fat diet have increased mortality and disturbed immune response in sepsis.

Authors:  Louise Strandberg; Margareta Verdrengh; Maria Enge; Niklas Andersson; Sylvie Amu; Karin Onnheim; Anna Benrick; Mikael Brisslert; Johan Bylund; Maria Bokarewa; Staffan Nilsson; John-Olov Jansson
Journal:  PLoS One       Date:  2009-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.